Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

697 public trials 122 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

American Ginseng in Treating Patients With Fatigue Caused by Cancer

NCT00719563

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Aurora Presbyterian Hospital Aurora, Colorado, United States

Boulder Community Hospital Boulder, Colorado, United States

Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States

View all 326 locations

View Trial Details

Completed

Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT

NCT01810120

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Hematologic Diseases, +17 more
Locations: Department of Oncology/Hematology of the Hospital Bambino Gesù (Roma) Rome, Italy

View Trial Details

Completed

Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

NCT00104975

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +58 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

View Trial Details

Completed

A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes

NCT00384956

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

NCT00683046

Conditions: Acute Myelogenous Leukemia, Anemia, Anemia, Aplastic, +41 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Safety, Tolerability, and Efficacy of Deferasirox in MDS

NCT00469560

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: SOC EMATOLOGIA ASO SS Antonio e Biagio Alessandria, Italy

Ist.Ematologia e Oncologia Medica L.e A. Seragnoli Bologna, Italy

CTMO-Ematologia Ospedale Binaghi Cagliari, Italy

Ospedale "A. Businco" Cagliari, Italy

View all 17 locations

View Trial Details

Completed

Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality.

NCT01718379

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +4 more
Locations: Hematology Dpt, Service d'Hématologie Clinique CHU Albert Michallon, Grenoble, France

Hematology Dpt, CHR La Source orléans Orléans, France

Chu Amiens Amiens, France

CHU Angers Angers, France

View all 48 locations

View Trial Details

Completed

Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

NCT02084563

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +29 more
Locations: Hospital Israelita Albert Einstein São Paulo, Brazil

View Trial Details

Completed

Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS

NCT00025662

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +31 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)

NCT00691938

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Washington University St Louis, Missouri, United States

View Trial Details

Myelodysplastic Syndromes

Myelodysplastic Syndromes trial results

Related conditions